<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Astaxanthin (ATX) is a dietary <z:chebi fb="2" ids="23044">carotenoid</z:chebi> of crustaceans and fish that contributes to their coloration </plain></SENT>
<SENT sid="1" pm="."><plain>Dietary ATX is important for development and survival of salmonids and crustaceans and has been shown to reduce cardiac ischemic injury in rodents </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to examine whether ATX can protect against ischemic injury in the mammalian brain </plain></SENT>
<SENT sid="3" pm="."><plain>Adult rats were injected intracerebroventricularly with ATX or vehicle prior to a 60-min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) </plain></SENT>
<SENT sid="4" pm="."><plain>ATX was present in the infarction area at 70-75 min after <z:hpo ids='HP_0003674'>onset</z:hpo> of MCAo </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with ATX, compared to vehicle, <z:mp ids='MP_0001399'>increased locomotor activity</z:mp> in <z:hpo ids='HP_0001297'>stroke</z:hpo> rats and reduced <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> at 2 d after MCAo </plain></SENT>
<SENT sid="6" pm="."><plain>To evaluate the protective mechanisms of ATX against <z:hpo ids='HP_0001297'>stroke</z:hpo>, brain tissues were assayed for free radical damage, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and excitoxicity </plain></SENT>
<SENT sid="7" pm="."><plain>ATX antagonized <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-mediated loss of aconitase activity and reduced <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release, <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, translocation of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi>, and TUNEL labeling in the ischemic cortex </plain></SENT>
<SENT sid="8" pm="."><plain>ATX did not alter physiological parameters, such as body temperature, brain temperature, cerebral blood flow, blood gases, blood pressure, and pH </plain></SENT>
<SENT sid="9" pm="."><plain>Collectively, our data suggest that ATX can reduce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-related injury in brain tissue through the inhibition of <z:mp ids='MP_0003674'>oxidative stress</z:mp>, reduction of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release, and antiapoptosis </plain></SENT>
<SENT sid="10" pm="."><plain>ATX may be clinically useful for patients vulnerable or prone to ischemic events </plain></SENT>
</text></document>